Drug
Quabodepistat clinical trials
- studies test it
- 5
- open now
- 1
- in phase 3
- 0
- first study started
- 2018
Keep track of what changes. Save the quabodepistat studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Combined with it in one product
Studies by the year they started
5 studies that test it; most in 2022 (2)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 1
Otsuka Pharmaceutical Development & Commercialization, Inc. (4) · University College, London (1)
Often tested with
Tested in the same studies.
OPC-67683 (3) · Bedaquiline (2) · Itraconazole (1) · Carbamazepine (1) · Ganfeborole (1) · BTZ-043 (1) · Pretomanid (1) · Moxifloxacin (1)
Studies
Open first, then newest update. How each study uses quabodepistat is read from its arms, and is right about nine times in ten.
Testing it · 5
- Platform Assessing Regimens and Durations In a Global Multisite Consortium for TBRecruitingPhase 2University College, LondonNCT06114628Written as Quabodepistat (Q)
- Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TBCompletedPhase 2Otsuka Pharmaceutical Development & Commercialization, Inc.NCT05221502Written as OPC-167832 10 mg
- A Study to Test the Effects of Itraconazole and Carbamazepine on OPC-167832 in Healthy Men and WomenCompletedPhase 1Otsuka Pharmaceutical Development & Commercialization, Inc.NCT07542847Written as OPC-167832
- A Study to Detect Radioactivity of [14C]-OPC-167832 in Urine and Feces in Healthy MenCompletedPhase 1Otsuka Pharmaceutical Development & Commercialization, Inc.NCT07314320Written as [14C]-OPC-167832
- A Phase 1/2 Trial of Multiple Oral Doses of OPC-167832 for Uncomplicated Pulmonary TuberculosisCompletedPhase 1/2Otsuka Pharmaceutical Development & Commercialization, Inc.NCT03678688Written as 10 mg OPC-167832
Given in every arm · 1 — quabodepistat is usual care beside what is tested
Codes
What other systems call quabodepistat · ClinicalTrials.gg INT014342
- UNII (FDA) 1PQN78P4S3QUABODEPISTATOne source FDA
- NCI Thesaurus C188494QuabodepistatOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 1PQN78P4S3 | QUABODEPISTAT | One source FDA |
| NCI Thesaurus | C188494 | Quabodepistat | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.